A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).

	A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).
	Yang, Yunpeng ; Zhao, Yuangyuan ; Zhou, Ting ; Chen, Gang ; Huang, Yan ; Liu, Feng ; Liu, Zhigang ; Qu, Song ; Lei, Yu ; Chen, Xiaozhong
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2022-06-01
卷号	40
ISSN号	0732-183X
资助项目	Jiangsu Hengrui Pharmaceuticals Co., Ltd.
WOS研究方向	Oncology
语种	英语
出版者	LIPPINCOTT WILLIAMS & WILKINS
WOS记录号	WOS:000863680301723
资助机构	Jiangsu Hengrui Pharmaceuticals Co., Ltd.
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/129853]
专题	中国科学院合肥物质科学研究院
作者单位	1.Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China 2.Sun Yat Sen Univ, Canc Ctr, Med Oncol Dept, Guangzhou, Peoples R China 3.Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China 4.Hunan Canc Hosp, Changsha, Peoples R China 5.Sun Yat Sen Univ, Affiliated Hosp 5, Canc Ctr, Zhuhai, Peoples R China 6.Guangxi Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Nanning, Peoples R China 7.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 8.Guangzhou Univ TCM, Affiliated Hosp 1, Guangzhou, Peoples R China 9.900 Hosp Joint Logist Support Force Chinese Peo, Fuzhou, Peoples R China 10.Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Yang, Yunpeng,Zhao, Yuangyuan,Zhou, Ting,et al. A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA	Yang, Yunpeng.,Zhao, Yuangyuan.,Zhou, Ting.,Chen, Gang.,Huang, Yan.,...&Zhang, Li.(2022).A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC)..JOURNAL OF CLINICAL ONCOLOGY,40.
MLA	Yang, Yunpeng,et al."A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-beta, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).".JOURNAL OF CLINICAL ONCOLOGY 40(2022).